BioCentury
ARTICLE | Financial News

Akari raises $17.4M follow-on

November 3, 2017 6:32 AM UTC

On Oct. 18, autoimmune and inflammatory disease company Akari Therapeutics plc (NASDAQ:AKTX) raised $17.4 million through the sale of 3.5 million ADSs at $5 per share in a follow-on underwritten by C...

BCIQ Company Profiles

Akari Therapeutics plc